Baloise stock holds after 2025 earnings and capital metrics

Baloise stock reflects the insurer's 2025 base, with Baloise Holding AG (ISIN CH0012410517) reporting CHF 2.01 billion in revenue and CHF 528.9 million in non-life claims in 2025. The company also reported a net loss of CHF 213.1 million for 2025, after a net profit of CHF 384.2 million in 2024, while the board proposed a dividend of CHF 8.10 per share for 2025.

2025 numbers set the tone

Those figures matter because the year-on-year swing in profit was large and visible: net income moved from CHF 384.2 million in 2024 to a CHF 213.1 million loss in 2025. Revenue remained at CHF 2.01 billion in 2025, which gives investors a cleaner view of how claims and capital items affected the result more than top-line volume.

Baloise also reported a solvency ratio of 210.9% at year-end 2025. That level is an important anchor for a Swiss insurer because it shows the group still ended the year with a sizeable regulatory capital buffer despite the loss.

Capital and payout matter

The proposed dividend of CHF 8.10 per share for 2025 is another central number because it shows how management framed the year-end balance between earnings pressure and shareholder returns. The comparison with the 2024 profit of CHF 384.2 million underlines that the payout proposal comes after a weaker earnings year, not a stronger one.

For investors, the combination of CHF 2.01 billion in revenue, CHF 213.1 million in net loss, and 210.9% solvency is more informative than a simple headline about performance. It points to a company that kept its capital position intact while absorbing a sharp earnings reset in 2025.

Insurance operations in focus

The non-life claims figure of CHF 528.9 million shows where pressure showed up in the operating account during 2025. That number matters alongside the revenue line because it helps explain why top-line stability did not translate into positive net income.

Baloise's 2025 result also stands out against the 2024 net profit of CHF 384.2 million, which means the earnings comparison is negative by CHF 597.3 million year on year. That is the clearest quantified comparison in the set and the one that best explains why the stock can trade on capital strength as much as on earnings.

Business line backdrop

In practical terms, Baloise's product mix is anchored in property and casualty, life, and asset-management-linked insurance services across its core markets. That mix matters because it ties the 2025 claims load and solvency ratio back to the everyday insurance book rather than to one-off financial items alone.

The current focus for the share is therefore not a single launch or product surprise, but the way the 2025 numbers frame the next reporting cycle. Revenue at CHF 2.01 billion and solvency at 210.9% provide the clearest operating and capital markers.

Share level and market view

Baloise stock can be discussed with the 2025 report context even without a fresh price print in hand, because the market-relevant numbers already show the size of the earnings reset. The most recent figures in the article are the year-end 2025 results: revenue CHF 2.01 billion, net loss CHF 213.1 million, solvency 210.9%, and proposed dividend CHF 8.10 per share.

That set gives a clean frame for the share: weaker earnings, preserved capital, and a payout proposal that signals continuity rather than expansion.

Baloise insurance mix

Baloise Holding AG sells insurance and related financial services across non-life, life, and asset-linked products. In 2025, the non-life claims burden of CHF 528.9 million was the most concrete operating drag visible in the numbers used here.

Stock closing view

Baloise stock is best read through the 2025 report metrics in this article: CHF 2.01 billion revenue, CHF 213.1 million net loss, 210.9% solvency, and CHF 8.10 proposed dividend per share. Those figures are the relevant dated anchors for the share context used here.